EUVIMEDEUVIMED entdecken
Crossref

Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics

Kazushige MAKI

Translational and Regulatory Sciences · 2020 · 2 (3) · 90-93

DOI: 10.33611/trs.2020-010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational and Regulatory Sciences, 2020. Verfasst von Kazushige MAKI. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

MAKI, K. (2020). Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics. Translational and Regulatory Sciences, 2(3), 90-93. https://doi.org/10.33611/trs.2020-010

Vancouver

MAKI K. Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics. Translational and Regulatory Sciences. 2020;2(3):90-93. doi:10.33611/trs.2020-010

BibTeX
@article{MAKI2020,
  author = {MAKI, Kazushige},
  title = {Preclinical safety assessments of mRNA-targeting oligonucleotide therapeutics},
  journal = {Translational and Regulatory Sciences},
  year = {2020},
  volume = {2},
  number = {3},
  pages = {90--93},
  doi = {10.33611/trs.2020-010}
}
Kostenlos starten →